FG
FGIWW
FGI Industries Ltd.
$0.0352
0.00%
$77.6K
No data for this timeframe.
Vol
Market Cap$77.6K
Cap SizeNano Cap
SEC Reports3
Exchange Nasdaq·Sector Heating Equip, Except Elec & Warm Air; & Plumbing Fixtures·Inc. E9·CIK 0001864943·Prev Close $0.0352
Recent Activity
May 14, 2026
SEC
FGI Industries reported Q1 2026 revenue of $30.5M, down 8.2% YoY, and a GAAP net loss of $0.50 per diluted share, wideni
8-K — Impact 6/10
Apr 23, 2026
SEC
FGI Industries Ltd. dismissed its auditor CBIZ CPAs P.C. and appointed Marcum Asia CPAs LLP as its new independent regis
8-K — Impact 7/10
Apr 21, 2026
SEC
FGI Industries reported Q4 2025 revenue of $30.5 million, down 14.4% year-over-year, and a net loss of $2.6 million, or
8-K — Impact 7/10
Latest Reports
BEARISH
8-K
6/10
FGI Industries reported Q1 2026 revenue of $30.5M, down 8.2% YoY, and a GAAP net loss of $0.50 per diluted share, wideni
May 14, 2026
BEARISH
8-K
7/10
FGI Industries Ltd. dismissed its auditor CBIZ CPAs P.C. and appointed Marcum Asia CPAs LLP as its new independent regis
Apr 23, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 0 neutral. Avg impact: 6.7/10.
BEARISH
8-K
6/10
FGI Industries reported Q1 2026 revenue of $30.5M, down 8.2% YoY, and a GAAP net loss of $0.50 per d
May 14, 2026
BEARISH
8-K
7/10
FGI Industries Ltd. dismissed its auditor CBIZ CPAs P.C. and appointed Marcum Asia CPAs LLP as its n
Apr 23, 2026
BEARISH
8-K
7/10
FGI Industries reported Q4 2025 revenue of $30.5 million, down 14.4% year-over-year, and a net loss
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 9.2% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 2.9% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 3.6% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 5.5% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.